Strides Pharma Reaches 9 US OTCs With Naproxen

OTC NDA Approvals Continue As Launch Date Nears For FDA’s Overhauled Monograph Program

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.